Orchid Pharma Ltd

NSE: ORCHPHARMA · BSE: 524372 · Pharmaceuticals & Biotechnology · 15 announcements

Share price: ₹1,064.90
Market cap: ₹6,377 Cr
Revenue (annual): ₹811.3 Cr
Net profit (annual): ₹20.55 Cr
P/E (TTM): 735.8×Sector 50.4×
Promoter holding: 69.84%+0.00% QoQ
FII holding: 0.80%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 6 Financial Results 3 Management Change 1 Capital Structure Change 1 Board Meeting Outcome 1 Annual Report 1 Annual General Meeting 1 Acquisition 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

3 Sep 2026 20:11 IST NSE

Board Meeting Outcome

Orchid Pharma Board Meeting Outcome

Orchid Pharma appointed a cost auditor and designated Mr. Arjun Dhanuka as a Whole-Time Director. The board also set arrangements for the upcoming 33rd Annual General Meeting.

Read the filing ↗